Inspiration Healthcare Group
Market Cap
UK£26.1m
Last Updated
2020/04/01 03:35 UTC
Data Sources
Company Financials +
Executive Summary
Inspiration Healthcare Group plc, together with its subsidiaries, provides medical devices for use in critical care, operating theatre, and home healthcare applications worldwide.
Snowflake Analysis
Flawless balance sheet with reasonable growth potential.
Share Price & News
How has Inspiration Healthcare Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: IHC has not had significant price volatility in the past 3 months.
Market Performance
7 Day Return
-7.5%
IHC
2.3%
GB Medical Equipment
3.9%
GB Market
1 Year Return
4.6%
IHC
-1.5%
GB Medical Equipment
-22.4%
GB Market
Return vs Industry: IHC exceeded the UK Medical Equipment industry which returned -1.5% over the past year.
Return vs Market: IHC exceeded the UK Market which returned -22.4% over the past year.
Shareholder returns
| IHC | Industry | Market | |
|---|---|---|---|
| 7 Day | -7.5% | 2.3% | 3.9% |
| 30 Day | -0.7% | -15.6% | -16.1% |
| 90 Day | 1.5% | -18.7% | -26.1% |
| 1 Year | 4.6%4.6% | 0.3%-1.5% | -18.2%-22.4% |
| 3 Year | 20.4%20.4% | 5.0%0.2% | -11.7%-23.1% |
| 5 Year | n/a | 35.9%24.4% | 1.9%-21.5% |
Price Volatility Vs. Market
How volatile is Inspiration Healthcare Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall St
Is Inspiration Healthcare Group plc's (LON:IHC) P/E Ratio Really That Good?4 weeks ago | Simply Wall St
Inspiration Healthcare Group plc (LON:IHC) Is Employing Capital Very Effectively1 month ago | Simply Wall St
Does Inspiration Healthcare Group's (LON:IHC) Statutory Profit Adequately Reflect Its Underlying Profit?Valuation
Is Inspiration Healthcare Group undervalued compared to its fair value and its price relative to the market?
19.44x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: IHC (£0.68) is trading above our estimate of fair value (£0.13)
Significantly Below Fair Value: IHC is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: IHC is good value based on its PE Ratio (19.4x) compared to the Medical Equipment industry average (27.2x).
PE vs Market: IHC is poor value based on its PE Ratio (19.4x) compared to the UK market (12.8x).
Price to Earnings Growth Ratio
PEG Ratio: IHC is good value based on its PEG Ratio (0.7x)
Price to Book Ratio
PB vs Industry: IHC is overvalued based on its PB Ratio (3.5x) compared to the GB Medical Equipment industry average (2.8x).
Next Steps
Future Growth
How is Inspiration Healthcare Group forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
29.0%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IHC's forecast earnings growth (29% per year) is above the savings rate (0.5%).
Earnings vs Market: IHC's earnings (29% per year) are forecast to grow faster than the UK market (15.5% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: IHC's revenue (15.1% per year) is forecast to grow faster than the UK market (2.4% per year).
High Growth Revenue: IHC's revenue (15.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if IHC's Return on Equity is forecast to be high in 3 years time
Next Steps
Past Performance
How has Inspiration Healthcare Group performed over the past 5 years?
34.0%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: IHC has a high level of non-cash earnings.
Growing Profit Margin: IHC's current net profit margins (6.6%) are lower than last year (7.6%).
Past Earnings Growth Analysis
Earnings Trend: IHC's earnings have grown significantly by 34% per year over the past 5 years.
Accelerating Growth: IHC's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: IHC had negative earnings growth (-10.3%) over the past year, making it difficult to compare to the Medical Equipment industry average (-7.4%).
Return on Equity
High ROE: IHC's Return on Equity (17.8%) is considered low.
Next Steps
Financial Health
How is Inspiration Healthcare Group's financial position?
Financial Position Analysis
Short Term Liabilities: IHC's short term assets (£7.0M) exceed its short term liabilities (£2.7M).
Long Term Liabilities: IHC's short term assets (£7.0M) exceed its long term liabilities (£472.0K).
Debt to Equity History and Analysis
Debt Level: IHC is debt free.
Reducing Debt: IHC had no debt 5 years ago.
Debt Coverage: IHC has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: IHC has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Inventory Level: IHC has a high level of physical assets or inventory.
Debt Coverage by Assets: IHC's debt is covered by short term assets (assets are 1.257765303932E+17x debt).
Next Steps
Dividend
What is Inspiration Healthcare Group's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate IHC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate IHC's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if IHC's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if IHC's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of IHC's dividend in 3 years as they are not forecast to pay a notable one for the UK market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
2.7yrs
Average management tenure
CEO
Neil Campbell (51yo)
17.25s
Tenure
UK£179,000
Compensation
Mr. Neil James Campbell serves as the Chief Executive Officer of Inspiration Healthcare Group plc. In 2003, Mr. Campbell became Chief Executive Officer and Founding Partner of Inspiration Healthcare Ltd. H ...
CEO Compensation Analysis
Compensation vs Market: Neil's total compensation ($USD222.86K) is below average for companies of similar size in the UK market ($USD333.37K).
Compensation vs Earnings: Neil's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 17.25yrs | UK£179.00k | 11.82% £3.1m | |
| CFO, Company Secretary & Executive Director | 3.58yrs | UK£152.00k | 0.089% £23.3k | |
| Commercial Director & Director | 4.83yrs | UK£151.00k | 10.16% £2.7m | |
| Head of Operations | no data | no data | no data | |
| Head of Marketing | 2.17yrs | no data | no data | |
| Head of R&D | 2.67yrs | no data | no data | |
| Head of Quality Assurance & Regulatory Affairs | 2.67yrs | no data | no data | |
| Group Financial Controller | 2.67yrs | no data | no data | |
| Finance Director | no data | UK£43.00k | 4.06% £1.1m |
2.7yrs
Average Tenure
51yo
Average Age
Experienced Management: IHC's management team is considered experienced (2.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 17.25yrs | UK£179.00k | 11.82% £3.1m | |
| CFO, Company Secretary & Executive Director | 3.58yrs | UK£152.00k | 0.089% £23.3k | |
| Commercial Director & Director | 4.83yrs | UK£151.00k | 10.16% £2.7m | |
| Non-Executive Chairman | no data | UK£35.00k | 0.63% £164.0k | |
| Non-Executive Director | 4.83yrs | UK£24.00k | 0.089% £23.3k | |
| Senior Independent Director | no data | UK£24.00k | no data |
4.8yrs
Average Tenure
56.5yo
Average Age
Experienced Board: IHC's board of directors are considered experienced (4.8 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Inspiration Healthcare Group plc's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Inspiration Healthcare Group plc
- Ticker: IHC
- Exchange: AIM
- Founded: 1998
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: UK£26.099m
- Shares outstanding: 38.38m
- Website: https://www.inspiration-healthcare.com
Number of Employees
Location
- Inspiration Healthcare Group plc
- Unit 2, Satellite Business Village
- Fleming Way
- Crawley
- West Sussex
- RH10 9NE
- United Kingdom
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| IHC | AIM (London Stock Exchange AIM Market) | Yes | Ordinary Shares | GB | GBP | Jun 2015 |
Biography
Inspiration Healthcare Group plc, together with its subsidiaries, provides medical devices for use in critical care, operating theatre, and home healthcare applications worldwide. The company offers neonatal intensive care products, such as Unique+ CFM, a wireless electroencephalography monitoring device; a nasal continuous positive airway pressure (nCPAP) device for treating infants, as well as a range of breathing circuits under the Inspire nCPAP name; inspiration air/oxygen blenders; and Tecotherm Neo, a servo control device for total body cooling and warming used in initial stabilization of preterm infants. Its neonatal intensive care products also include positioning products comprising DandlePAL, DandleROO, DandleROO Lite, DandleGel Pillow, and KangaROO Kuddler used to aid the neurodevelopment of infants; LifeStart, a neonatal bedside resuscitation unit; and Inspire rPAP, a 2-piece non-invasive system for the initial stabilization and resuscitation of infants. In addition, the company provides adult intensive care products; and AlphaCore5, a patient warming system for prevention of inadvertent hypothermia. Further, it offers various equipment maintenance packages; and a range of service kits, spare parts, blender exchange/overhaul programs, and repair services. The company was founded in 1998 and is headquartered in Crawley, the United Kingdom.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/04/01 03:35 |
| End of Day Share Price | 2020/03/31 00:00 |
| Earnings | 2019/07/31 |
| Annual Earnings | 2019/01/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.